Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 23, 2011
- Fourth quarter and year-end financial results to be released March 9, 2011 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 23 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host...
-
Oct 29, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of...
-
Oct 27, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three and nine months ended September 30, 2010. Q3 2010 Summary --------------- - Net revenue...
-
Oct 18, 2010
- Third quarter financial results to be released October 27, 2010 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Oct. 18 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...
-
Oct 7, 2010
Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release...